Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p79
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 79/162)
Character Range: 15080606–15089901

CN14309          Alendronic acid                                      Corticosteroid-induced osteoporosis
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         Patient must currently be on long-term (at least 3 months), high-dose (at least 7.5 mg per day prednisolone or equivalent) corticosteroid therapy; AND
                                                                                                         Patient must have a Bone Mineral Density (BMD) T-score of -1.5 or less; AND
                                                                                                         Patient must not receive concomitant treatment with any other PBS-subsidised anti-resorptive agent for this condition.
                                                                                                         The duration and dose of corticosteroid therapy together with the date, site (femoral neck or lumbar spine) and score of the qualifying BMD measurement must be documented in the patient's medical records when treatment is initiated.
C14311              P14311         CN14311          Valsartan with hydrochlorothiazide                   Hypertension
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         The treatment must not be for the initiation of anti-hypertensive therapy; AND
                                                                                                         The condition must be inadequately controlled with an angiotensin II antagonist.  or
                                                                                                         The condition must be inadequately controlled with a thiazide diuretic.
C14313              P14313         CN14313          Febuxostat                                           Chronic gout                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Compliance with Authority Required procedures - Streamlined Authority Code 14313
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         The condition must be either chronic gouty arthritis or chronic tophaceous gout; AND
                                                                                                         Patient must have a medical contraindication to allopurinol.  or
                                                                                                         Patient must have a documented history of allopurinol hypersensitivity syndrome.  or
                                                                                                         Patient must have an intolerance to allopurinol necessitating permanent treatment discontinuation.
C14318              P14318         CN14318          Apixaban                                             Pulmonary embolism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures - Streamlined Authority Code 14318
                                                                                                         Continuing treatment
                                                    Rivaroxaban                                          The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         Patient must have confirmed acute symptomatic pulmonary embolism.
C14319              P14319         CN14319          Thiamine                                             Thiamine deficiency                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Compliance with Authority Required procedures - Streamlined Authority Code 14319
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         The treatment must be for prophylaxis;
                                                                                                         Patient must be an Aboriginal or a Torres Strait Islander person.
C14322              P14322         CN14322          Calcitriol                                           Hypocalcaemia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures - Streamlined Authority Code 14322
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         The condition must be due to renal disease.
C14323              P14323         CN14323          Azacitidine                                          Acute Myeloid Leukaemia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Compliance with Authority Required procedures
                                                                                                         Dose escalation therapy - Continuing treatment
                                                                                                         Patient must have previously received PBS-subsidised treatment with this drug for this condition; AND
                                                                                                         Patient must have, in order to extend the dose